throbber
/.
`
`l
`
`First published in 1987 by Chapman and Hall Ltd
`11 New Fetter Lane, London EC4P 4EE
`Published in the USA by Chapman and Hall
`29 West 35th Street, New York, NY 10001
`© 1987 Adrien Albert
`Printed in Great Britain at the
`University Press, Cambridge
`ISBN 0 412 28800 1 (hb)
`ISBN 0 412 28810 9 (pb)
`This title is available in both hardbound and
`paperback editions. The paperback edition is sold
`subject to the condition thaf it shall not, by way of
`trade or otherwise, be'lent, resold, hired out, or
`otherwise circulated without the publisher's prior
`consent in any form of binding or cover other than that
`in which it is published and without a similar condition
`including this condition being imposed on the
`subsequent purchaser.
`All rights reserved. No part of this book may be
`reprinted, or reproduced or utilized in any form or by
`any electronic, mechanical or other means, now known
`or hereafter invented, including photocopying and
`recording, or in any information storage and retrieval
`sys~em, without permission in writing from the
`publisher.
`
`British Library Cataloguing in PublicatiQn Data
`
`Albert, Adrien
`Xenobiosis: foods, drugs and poisons
`in the human body.
`l. Xenobiotics
`I. Title
`615.7
`
`QP529
`
`ISBN 0-412-28800--1
`ISBN 0-412-2881Q--9 Pbk
`
`Library of Congress Qataloging in Publication Data
`
`Albert, Adrien.
`Xenobiosis: foods, d_rugs, and poisons in the human body.
`
`Bibliography: p.
`Includes indexes.
`1. Xenobiotics-Metabolism. 2. Biotransformation
`I. Title.
`(Metabolism)
`[DNLM:
`l. Biotransformation.
`2. Drugs-metabolism. 3. Food. 4. Poisons. QU 120
`A333x]
`QP80l.X45A43 1987
`ISBN 0-412-28800-l
`ISBN 0-412- 2881Q--9 (pbk.)
`
`87-11646
`
`615.9
`
`Contents
`
`Preface
`
`1
`
`Introduction to the concept: Xenobiosis
`
`PART ONE: FOODS
`
`2
`Introduction to Part One:Foods as foreign substances
`2.1 Our debt to Early man: the hazardous evolution of man's diet
`2.2
`Food from the beginning of civilization to the prese~t time
`2.3 The gastrointestinal tract and what it does to food
`
`3
`3.1
`
`The metabolism of foods
`The conversion of digested foods into energy: the storage and
`release of energy
`3.2 The conversion of metabolic fragments into human carbohydr-
`ate, lipid and protein
`
`Hidden dangers in wholesome foods
`4
`4.1 Quantitative malnutrition (overeating and undereating)
`4.2 Qualitative malnutrition (unbalanced diets)
`4.3
`Toxican~ occurring naturally in food
`
`5
`5.1
`5.2
`
`Special aspects of wholesome foods
`Inborn sensitivity to a particular food
`Enhancing the enjoyment of meals: herbs, spices and other
`additives
`5.3 Enhancement of mood at table
`
`PART TWO: DRUGS
`
`1
`
`7
`9
`13
`14
`
`18
`
`18
`
`31
`
`37
`39
`45
`57
`
`74
`74
`
`79
`92
`
`97
`
`6
`6.1
`
`Introduction to Part Two: Drugs as foreign substances
`The three classes of drugs currently used in therapy: some useful
`definitions
`
`99
`
`100
`
`PENN EX. 2059
`CFAD V. UPENN
`IPR2015-01836
`
`1 of 5
`
`

`
`186 Activity: how actions are related to chemical structure
`
`How one methyl group can change the action 187
`
`Multiple regression analysis has given some very useful results. It functions
`best in industry when a large series of closely related candidate drugs is on hand
`and a speedy indication is needed concerning what should be synthesized next.
`However for the purpose of finding scientific correlations among substances that
`are not closely related chemically, the biological situation is usually found to be
`more complex than such an equation can accommodate. For example the initial
`distribution of a drug need not depend on lipophilicity but on the use of
`facilitated channels that exist for the uptake of such natural products as sugars,
`purines, amino acids and even choline (p. 121). For these reasons those of a
`scholarly cast of mind, provided that they have the time and facilities, will
`continue to examine the connection between phy.okochemical properties and
`pharmacological action, in all their fine details' and rewarding complexity.
`In fact much steric and electronic information about receptors is available
`from sources other than regression analysis. For example, where the receptor is
`the active site on an enzyme, details (obtained by X-ray diffraction analysis) are
`often available from the Cambridge (UK) or Brookhaven (USA) crystal(cid:173)
`structure databanks. In other cases one can usefully superimpose (on a
`transparent surface) scale drawings of all the drugs that act on the receptor. The
`shared features constitute what is called a·'hyper-molecule' to which the receptor
`should be complementary in outline and charge (Balaban, et al., 1980). If an
`approximate image of the receptor can be generated on the screen of an Evans
`and Sutherland computer-graphics (computer controlled) Picture System the
`images of candidate drugs can then be applied in a contrasting colour. In this
`way the ability of the candidate to make a good fit may be judged (Blaney, et al.,
`1982).
`
`8.4 How one methyl group can significantly change the action of
`a drug
`
`It is quite common to find a pair of closely related molecules where the first has a
`strong biological action whereas the other has none. How can two such
`substances which may differ in composition by only a single methyl group
`perform so differently in a biological test? In this Section a study of methyl groups
`will be made as examples of what are commonly termed 'chemically inert'
`groups. Yet these groups if suitably placed can profoun~ly change the chemical
`behaviour of molecules by well-understood steric and electronic effects. Their
`altered biological properties reflect these changes.
`
`Steric influences
`
`The steric effects introduced by small, inert groups are of two kinds. Some are
`evident even in aqueous solution whereas others require a surface for manifest(cid:173)
`ation, as in enzyme reactions.
`
`(a) Steric inj/uences on solubility. It might be thought that the insertion into a given
`molecule of a methyl group would always lower solubility in water, because a
`methyl group is water-repelling. It usually does lower solubility but there are
`interesting exceptions. In order that a substance may dissolve in water the water
`molecules must be forced apart by breaking their hydrogen bonds. The lower
`alcohols, methanol and ethanol, readily do this because their hydroxyl group
`forms such a large part of each molecule and this group readily becomes
`hydrogen-bonded to water molecules. But in higher alcohols, the paraffinic side(cid:173)
`chain becomes a more dominant feature: it cannot be accommodated in the
`interstices, it cannot force the water molecules apart and hence it tends to be
`squeezed out of the water, dragging the whole molecule with it. This explains the
`low solubility of the higher alcohols. Yet this effect can be considerably lessened
`by shifting the hydroxyl group to the centre of the molecule, as in tertiary amyl
`alcohol, which is consequently more soluble than its lower homologue, normal
`butanol (Ginnings and Baum, 1937). No less surprising, the 2-aminobutyric
`acids are more soluble than 2-aminopropionic acid (alanine), because of chain(cid:173)
`folding.
`Unusual solubilizing effects of methyl groups are found in the antibacterial
`sulfonamides, e.g. sulfadiazine ( 8. 40), and in many other drugs of a similar degree
`of complexity and rigidity. In such molecules, any protruding C-methyl groups
`prevent strainless adsorption of dissolved solute (drug) on to the crystal-lattice of
`the solid phase. This anomaly displaces the final equilibrium in the direction of
`increased solubility (Gilligan and Plummer, 1943).
`A methyl group can hinder adqition of water across an adjacent double bond
`thus greatly increasing the lipophilicity of the substance, a property on which
`activity is apt to depend. Such addition of water is known as covalent hydration
`(Albert, 1976). Several naturally-occurring pteridines such as xanthopterin
`(8.51) which is present in the human kidney, are covalently hydrated, i.e. have
`become secondary alcohols. However the addition of a methyl group, as in ( 8.52),
`largely suppresses the hydration giving a less hydrophilic molecule. Many other
`natural products are covalently hydrated, a characteristic that can be suppressed
`by a neighbouring C-methyl group.
`
`(b) Steric inj/uence on chelation. The antibacterial action of 8-hydroxyquinoline
`(Section 8.3) is seriously decreased if a methyl group is inserted in the 2-position
`(Albert, et al., 194 7). This deactivation is most likely exerted through a steric
`
`H~~
`
`H)(_W,lLNAo
`H H
`Xanthopterin
`(8.&1)
`
`oy~~~
`Me~JlNAO
`
`H
`7-Methylxanthopterin
`(8.&2)
`
`PENN EX. 2059
`CFAD V. UPENN
`IPR2015-01836
`
`2 of 5
`
`

`
`188 Activity: how actions are related to chemical structure
`
`How one methyl group can change the action 189
`
`effect at the biological interface. Even in solution this substance (2-methyl-8-
`hydroxyquinoline) has lost its affinity for Al 3 + (while retaining it for Fe3 +)
`because of the steric effect of the methyl group.
`
`(c) Steric influences on receptors and enzymes. Most molecules that fit the mqscarine
`receptor for acetylcholine have a quaternary nitrogen atom of which one
`substituent is a straight chain of five atoms in length. Addition of one more
`methylene group to this chain causes a dramatic loss of biological effect. At least
`two of the other substituents on the nitrogen atom must be methyl groups to
`achieve maximal action. If one of these is substituted by either hydrogen or ethyl,
`a sharp drop in activity takes place. On p. 100 we-noted how the addition of a
`methyl group to the molecule of acetylcholine ""(6.2) to give methacholine ( 6.1)
`hindered hydrolysis ofthe molecule by acetylcholinesterase so strong~y that the
`momentary pharmacological action exerted by ACh became a durable, and
`clinically valued, one. The biological effect of the vitamin thiamine (8.53) is very
`sensitive to addition or loss of a methyl group. When tested on pigeons, the
`activity drops to 5% if the methyl group is removed from the pyrimidine ring,
`and to less than l% if the methyl group is removed from the thiazole ring. Finally
`if an extra methyl group is inserted into "the thiazole ring, between nitrogen and
`sulfur, the vitamin action is completely lost (Schultz, 1940).
`Sometimes a methyl group increases the biological effect of a drug by making it
`a poorer fit for a destructive enzyme. Thus amphetamine (7.24), which is l(cid:173)
`methyl-2-phenylethylamine, has a much more prolonged hypertensive effect
`than 2-phenylethylamine. This has been traced to the resistance of amphetamine
`to monoamine oxidase, the enzyme that quickly destroys the lower homologue
`(Blaschko, 1952). Similarly, the action of corticosteroids and the steroid sex
`hormones can be intensified by inserting a methyl, or a fluorine, substituent-a
`steric device that has produced several clinically valuable drugs. Such seemingly
`inert substituents turn the steroids into poorly-fitting substrates for their natural
`destructive enzymes (Ringold, 1961).
`
`Electronic influences
`
`The methyl group is the commonest substituent that releases electrons no matter
`whether inductive or mesomeric mechanisms·are operating.
`
`(a) Electronic influences on ionization•. Because of its electron-releasing nature a
`methyl group, if attached to a nearby carbon atom, strengthens a base and
`weakens an acid. Also a methyl group attached to nitrogen, to give a secondary
`amine, is base-strengthening although most tertiary amines are weaker than
`secondary amines. Such changes in strength are usually less than one pK unit but
`can influence biological results if the pK falls within one unit of the pH at which
`
`• For more on ionization see Albert and Seijeant (1984) .
`
`the biological test is made. When as usually happens one ionic species (e.g. the
`cation) is far more biologically active than another (e.g. the neutral species) this
`change in ionization can decide whether a substance is biologically active or not.
`The triphenylmethane dyestuffs (8.54), which show a large increase in basic
`strength upon N-alkylation, illustrate how antibacterial action is correlated with
`ionization in this series as Table 8.5 illustrates. Thus antibacterial activity is
`virtually cr~ated here by the insertion of 'chemically inert groups'.
`Although it is obvious that methylation of an acidic group must abolish its
`ability ~o ionize, the consequences of such a methylation in the barbituric acid
`series are particularly interesting. In aqueous solution, barbituric acid exists in
`the trioxo form ( 8.55) and forms the mono-anion by loss of a proton from C-5. It is
`
`Table 8.5 Connexion between ionization and antibacterial activity in .a series of
`triphenylmethane bases.
`
`Substance
`
`Formula
`
`pKequil·
`
`Percentage
`ionized
`at
`pH7.3
`
`Doebner's violet
`Malachite green
`Brilliant green
`
`(8.54a)
`(8.54b)
`(8.54c)
`
`5.38
`6.90
`7.90
`
`2
`28
`80
`
`From Gold.acre and Philips, 1949
`
`Minimal
`bacteriostatic
`concentration
`(Staph. aureus;
`24 hat 37"C
`and pH 7.3)
`
`I in
`20000
`I in
`80000
`I in 1280000
`
`Thiamine
`(8.53)
`
`2
`a.n
`
`NR 2
`R2 N+
`(8.54) a. R = H: Doebner's violet
`b. R = CH 3 : Malachite green
`c. A= C2 H 5 : Brilliant green
`
`PENN EX. 2059
`CFAD V. UPENN
`IPR2015-01836
`
`3 of 5
`
`

`
`How one methyl group can change the action 191
`
`selectivity can be introduced into a molecule, and what rules govern it, will be
`discussed in Chapter 9.
`
`Further reading
`
`For the biological effects of inserting chemically-inert substituents, see Albert,
`1985, pp. 43-5Q.
`
`Follow-up
`
`Consider the traditional (and apparently unsinkable) phrase 'structure-activity
`relationships' (SAR) and discuss the extent to which the word 'structure' retains
`its original meaning. Could you think of a better phrase?
`
`190 Activity: how actions are related to chemical structure
`
`a fairly strong acid (pKa 3.9). The insertion of two alkyl groups into the 5-position
`removes any possibility of an anion being formed in the 5-position. Consequently
`the anion is formed from N-3 but is much weaker. Thus barbital (5,5-
`diethylbarbituric acid) has a pKa of7 .9 and hence is 104 times weaker as an acid
`than barbituric acid! The consequences of the insertion of these ethyl groups on
`the structure-activity relationship is momentous. A substance with a pKa of3.9 is
`completely ionized at pH 7 .3, and hence unlikely to pass the blood-brain barrier.
`However when as in barbital the pKa is 7.9 the substance is 80% non-ionized at
`pH 7.3, and hence passes through without difficulty.
`
`(b) Electronic influences on reduction-oxidation potentials. '!'he electrons released to
`the rest ofthe molecule by a C-methyl substituent lower the redox potential (E0
`).
`As a result the affected substance becomes a more active reducing agent (and is
`more easily oxidized) than the unmethylated homologue. Redox potentials are
`used to record the equilibrium between oxidized and reduced forms.
`An example of this lowering of E 0 is the insertion of a methyl group into the
`2-position of 1,4"-naphthaquinone which depresses the potential (by 76 mV) to
`408 m V (Fieser and Fieser, 1935). In another example the reduction potential of
`NAD (p. 20) is -180m V, a value so low ·that a substituted NAD of slightly
`lower potential could, most likely, not become reduced to its NADH. Any
`analogue that cannot be reduced in the living cell cannot act as a hydrogen
`carrier. It is apparently for this reason that 2-methyl-nicotinamide has no
`biological activity, even if the effect of the methyl group may be partly steric.
`
`(c) Electronic irifluences on reactions where a covalent bond is broken. The electron(cid:173)
`releasing effects of a methyl group described above were of an instantaneously(cid:173)
`appearing character. Some time-dependent, i.e. kinetically controlled, effects
`will now be mentioned. Methyl groups, because of their electron-releasing
`properties, promote electrophilic substitution, e.g. they make neighbouring
`amino groups readier to be acylated or to form an azomethine (Schiff base). A
`methyl group also constitutes a side-chain that is conveniently biodegraded.
`Thus the metabolic oxidation of a methyl group to a carboxylic acid confers
`hydrophilic properties on a highly lipophilic molecule and leads to rapid
`excretion in the urine.
`
`(tf) Solubility. In an aromatic nitrogen-heterocycle such as pyridine replacement
`by methyl of the hydrogen atom in an-OH, -NH 2 or-C(: O)NH- group usually
`increases solubility in water dramatically. Thus 6-aminopurine (adenine) is
`soluble to the extent of only I part in 1100, whereas 6-dimethylaminopurine
`dissolves 1 in 120 (Albert and Brown, 1954); countless similar examples are
`known.
`
`In conclusion it must be pointed out that this Chapter deals only with activity,
`which is the quality that makes a molecule more biologically active than a food.
`Yet activity can create only a poison unless selectivity is also incorporated. How
`
`PENN EX. 2059
`CFAD V. UPENN
`IPR2015-01836
`
`4 of 5
`
`

`
`9
`Selectivity: designing drugs
`without side-effects.
`The three sources of--selectivity
`
`9.1 Selectivity through comparative distribution 193
`9.2 Selectivity through comparative biochemistry 198
`9.3 Selectivity through comparative cytology 207
`
`In Chapter 8 we saw how a biologically inert molecule could be redesigned to
`endow it with biological activity. However that would be only the first step in the
`creation of a useful drug because a biologically active substance remains only a
`toxicant (poison) until it is provided with selectivity also. In other words, it must
`be further designed to confine its action to the uneconomic cells (p. lO 1). The
`extent to which a drug can differentiate between economic and uneconomic cells
`is the measure of its selectivity. Toxicity in a drug is no drawback, in fact it is the
`very core of its usefulness. What is important is to arrange for this toxicity to be
`selective. The present Chapter lists and examines the properties from which
`selectivity can be derived.
`Realization of the importance of selectivity dates from about 191 I when Paul
`Ehrlich introduced his chemotherapeutic index as the first means of measuring it
`(p. 111). Today the drug designer's goal is complete selectivity and this has been
`closely approached in several chemotherapeutic agents such as the penicillins,
`the antibacterial sulfonamides and several anthelminthics such as piperazine.
`However for some diseases the best available drugs still have only partial
`selectivity although current research is ·Steadily improving on this position.
`Since 1948 I have been seeking and publicly discussing the principles that can
`introduce selectivity into a biologically-active molecule. This search led me to
`conclude that three main principles govern this phenomenon:
`
`1. Comparative accumulation, by choice of a toxicant that accumulates pre(cid:173)
`ferentially in the uneconomic cells;
`2. Comparative biochemistry, by choice of a toxicant that injures a biochemical
`process found only in the uneconomic cells;
`
`I
`
`Comparative distribution 193
`
`3. Comparative cytology, by choice of a toxicant that interferes with a cytological
`feature peculiar to the uneconomic cells.
`How these principles, singly or jointly, can establish selectivity in otherwise
`unselective toxicants will now be discussed under these three headings.
`
`9.1 Selectivity through comparative distribution
`
`Many substances that could be toxic for almost all kinds of cells can nevertheless
`be made highly selective by favourable differences in distribution. This applies
`even to the hydrogen ion (H+) surely the simplest of all biologically-active
`agents. In the form of 10% sulfuric acid, it can safely be sprayed on emerging
`cereal crops to destroy weeds, as was discovered in France by Rabate and
`confirmed in the University of California's field trials. Of course, sulfuric acid is
`injurious to the cytoplasm of both wheat and weed, but two factors restrain it
`from penetrating the cereal. Firstly the exterior of the cereal, a monocotyledon, is
`smooth and waxy whereas that of the weeds (mainly dicotyledons) is roughand
`absorbent; hence the acid runs off the former but is accumulated by the latter.
`Secondly the tender new shoot of the cereal arises from the soil and is protected by
`a leaf-sheath whereas the growing point of the dicotyledon is exposed and
`vulnerable because it forms the apex of the shoot. Hence the weeds die and the
`economic crop persists because of a selective action that depends entirely on
`distribution. (Unfortunately, acidification of the soil limits this type of weeding
`to a single season).
`Human medicine provides many similar examples, notably the tetracyclines
`(e.g. 9.1) which are, after the penicillins, the most frequently prescribed of all
`<;Lntibiotics. Franklin, working in Manchester, observed that the tetracyclines are
`accumulated by all bacteria whereas they hardly penetrate mammalian cells
`thanks to a difference in the cytoplasmic membranes of these two forms oflife. As
`a result the synthesis of proteins by bacterial ribosomes is repressed and the
`bacteria die. Yet when both the economic and uneconomic cells were fractiona(cid:173)
`ted it was found that the ribosomes of the host were just as sensitive to these
`antibiotics as those.of the parasites. However so selective is the distribution of
`these drugs that the tetracyclines do not normally reach the ribosomes in
`mammalian cells. Hence the high . therapeutic index of these antibiotics
`(Franklin, 1971).
`Selective partitioning is possible between the tissues of a single organism. In a
`rare example from anticancer therapy, 5-fluorouracil (9.2) is used by dermatolo(cid:173)
`gists to eliminate two malignant growths- basal and squamous cell carcinomas.
`So selective is this drug that patients are encouraged to rub a solution of it daily
`into the affected area. The eventual action is on thymidylate synthetase which is
`present in both healthy and malignant tissues. However the malignant tissue in
`this treatment is the only one to become inflamed. It finally disintegrates by
`necrosis and is replaced by healthy granulation tissue followed by new skin
`(Klein et al., 1972).
`
`PENN EX. 2059
`CFAD V. UPENN
`IPR2015-01836
`
`5 of 5

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket